MedWatch

Novo CEO condemns invasion of Ukraine – but keeps Russian factory running

Despite the invasion of Ukraine, pharmaceutical firm Novo Nordisk keeps the operations of its factory in Russia running. Employees in Ukraine have gone unharmed, the company also reports.

Lars Fruergaard Jørgensen, CEO of Novo Nordisk | Photo: Stine Bidstrup/ERH

CEO of Novo Nordisk Lars Fruergaard Jørgensen has for the first time commented directly on Russia’s invasion of Ukraine – which he is firmly against, it should come as no surprise.

”Novo Nordisk condemns the invasion of Ukraine,” Fruergaard Jørgensen declares at the company’s annual general meeting.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs